Jump to main content
Jump to site search

Issue 42, 2015
Previous Article Next Article

Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B

Author affiliations

Abstract

We report the synthesis, characterization and evaluation of lecithin-drug hybrid nanocarriers (NCs) with enhanced oral bioavailability and anti-parasitic potential for poorly water-soluble drugs. Amphotericin B (AmB), a poor water-soluble drug with poor membrane penetrating ability, was selected as a model drug to demonstrate the potential of the lecithin-drug hybrid NCs. Lec-AmB NCs were prepared by the self-assembly of lecithin into nanoparticles (NPs) at a critical micellar concentration of 4 mg ml−1 and into liposomes at a critical liposomal concentration of 53 mg ml−1 in aqueous systems. The Lec-AmB NPs (200–300 nm) were further coated with polyethylene glycol (MW 600) and Tween 20, whereas the liposomes (70–90 nm) were used as such for this study. The Lec-AmB NCs were evaluated for their ability to boost in vivo oral pharmacokinetic parameters in rabbits and in vitro anti-leishmanial activity against the promastigotes of Leishmania tropica. A reciprocal relationship was observed between the size and drug encapsulation efficiency of the NPs, but no such relationship was observed in the case of the liposomes. More importantly, the oral bioavailability and anti-leishmanial activity of Lec-AmB NPs was enhanced up to 21- and 6.3-fold, and 21- and 2-fold, respectively, in the case of the liposomes. The improvement in the bioavailability and anti-leishmanial activity is very significant compared to the deoxycholate complex of AmB (water soluble, injectable market product: Anfotericina FADA®), and this study, thus shows the promising potential of easy-to-prepare NCs with improved therapeutic efficiency using phosphocholine-based biocompatible surfactants.

Graphical abstract: Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B

Back to tab navigation

Publication details

The article was received on 27 Jun 2015, accepted on 08 Sep 2015 and first published on 09 Sep 2015


Article type: Paper
DOI: 10.1039/C5TB01258A
Author version
available:
Download author version (PDF)
Citation: J. Mater. Chem. B, 2015,3, 8359-8365
  •   Request permissions

    Synthesis, characterization and evaluation of lecithin-based nanocarriers for the enhanced pharmacological and oral pharmacokinetic profile of amphotericin B

    I. Javed, S. Z. Hussain, I. Ullah, I. Khan, M. Ateeq, G. Shahnaz, H. U. Rehman, M. T. Razi, M. R. Shah and I. Hussain, J. Mater. Chem. B, 2015, 3, 8359
    DOI: 10.1039/C5TB01258A

Search articles by author

Spotlight

Advertisements